Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 27, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Reni Benjamin Downgraded (ACET) to Hold on, Jun 27th, 2023
Reni Benjamin of JMP Securities, Downgraded "Adicet Bio, Inc." (ACET) to Hold on, Jun 27th, 2023.
Reni has made no other calls on ACET in the last 4 months.
There are 2 other peers that have a rating on ACET. Out of the 2 peers that are also analyzing ACET, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Brian Cheng of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $6 on, Thursday, June 1st, 2023
This is the rating of the analyst that currently disagrees with Reni
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $30 on, Wednesday, May 10th, 2023
